The Centers for Disease Control and Prevention (CDC) published updated guidance communicating to the public that the coronavirus disease 2019 is an airborne threat, explicitly stating that transmission and subsequent infection with the novel coronavirus can occur via inhalation of very fine respiratory droplets as well as aerosolized particles.
The governors of two more U.S. states said on May 6 they were lifting most restrictions that were put in place to combat the spread of the novel coronavirus after sharp drops in infection rates and deaths.
Fujifilm Holdings Corp. said on April 21 the company started a new phase III trial in Japan of the drug Avigan for Covid-19, reviving hopes for a home-grown treatment for the virus.
According to separate studies, blood type does not affect susceptibility to Covid-19 in U.S. patients and an inhaled steroid commonly used to treat asthma can help keep patients with mild Covid-19 from getting sicker.
Shares of Inovio climbed in trading after the company announced its DNA vaccine candidate for Covid-19 induced a robust T-cell response against multiple variants of the SARS-CoV-2 virus.
The United States delivered about 3 million Covid-19 vaccine doses per day on average over the past week, up 8% over the previous 7-day average, U.S. Centers for Disease Control and Prevention Director Rochelle Walensky said on April 7.
Three major U.S. drug distributors requested the government to expand the Covid-19 vaccine supply chain network as the country strives to immunize its population against the novel coronavirus as quickly as possible.
U.S. drugmaker Merck & Co. Inc. said on March 6 the experimental antiviral drug molnupiravir the company is developing with Ridgeback Bio showed a quicker reduction in infectious virus in its phase 2a study among participants with early Covid-19.
A recent study published in Science Translational Medicine shows that a new flu vaccine appears to protect monkeys against influenza strains that are likely to cause a global pandemic, giving researchers hope that this vaccine could hold the key to providing a future universal flu vaccine for humans.
The World Health Organization listed AstraZeneca’s Covid-19 vaccine for emergency use, widening access in the developing world, while sources said the EU is in talks with Moderna on buying more vaccines.
